24/7 Patient Assistance: 760-405-8205

James Posey , MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

  • Bio & Insurance Information

    Dr. James Posey graduated the medical school from Howard University College of Medicine and completed both his residency and fellowship program at Georgetown University Hospital. He is specialized in Medical Oncology and also board certified in Medical Oncology. Dr. Posey has been in practice for more than 20 years and is affiliated with University of Alabama Hospital. During his career, he has contributed to several publications of medical interest.

  • Education & Training


    Howard University College of Medicine

    Medical School


    Georgetown University Hospital



    Georgetown University Hospital


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    UAB Hospital

    Languages: English/Spanish

    (205) 934-3411

    1802 6th Ave S

    Birmingham, Alabama 35233

    Read More

    USA Children's & Women's Hospital

    Languages: English/Spanish

    (251) 415-1000

    1700 Center St

    Mobile, Alabama 36604

    Read More
  • Publications & Memberships

    Dr. James Posey has contributed to 3 publications.

    Patterns of Failure for Lymph Node-Positive Resected Pancreatic Adenocarcinoma After Adjuvant Radiotherapy or Gemcitabine-based Chemotherapy Alone.

    McDonald, A. M.,Dulaney, C. R.,López-Araujo, J.,Posey, J. A.,Keene, K. S.,Christein, J. D.,Heslin, M. J.,Wood, T. E.,Jacob, R.; J Gastrointest Cancer. 2015 Mar 19.

    See more >>

    Erratum to: Pancreatic adenocarcinoma: a pilot study of quantitative perfusion and diffusion-weighted breath-hold magnetic resonance imaging.

    Kim, H.,Arnoletti, P. J.,Christein, J.,Heslin, M. J.,Posey, J. A.,Pednekar, A.,Beasley, T. M.,Morgan, D. E.; Abdom Imaging. 2014 Jul 20.

    See more >>

    The effects of liver impairment on the pharmacokinetics of brivanib, a dual inhibitor of fibroblast growth factor receptor and vascular endothelial growth factor recep...

    El-Khoueiry, A.,Posey, J. A.,Castillo Ferrando, J. R.,Krishnamurthi, S. S.,Syed, S.,Kollia, G.,Walters, I.,Fischer, B. S.,Masson, E.; Cancer Chemother. Pharmacol.. 2013 Jul.

    See more >>